...
首页> 外文期刊>Annals of epidemiology >Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics.
【24h】

Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics.

机译:Premier:全面控制生活方式以控制血压的临床试验:原理,设计和基线特征。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To describe PREMIER, a randomized trial to determine the effects of multi-component lifestyle interventions on blood pressure (BP). METHODS: Participants with above optimal BP through stage 1 hypertension were randomized to: 1) a behavioral lifestyle (BLS) intervention that implements established recommendations, 2) a BLS intervention that implements established recommendations plus the DASH diet, or 3) an advice only standard of care group. The two BLS interventions consist of group and individual counseling sessions for 18 months. The primary outcome is systolic BP at 6 months. Additional outcomes include diastolic BP and homocysteine at 6 months; systolic and diastolic BP at 18 months; fasting lipids, glucose and insulin at 6 and 18 months; and effects in subgroup. CONCLUSION: Results from the PREMIER trial will provide scientific rationale for implementing multi-component behavioral lifestyle intervention programs to control BP and prevent CVD.
机译:目的:描述Premier,一项确定多成分生活方式干预措施对血压(BP)影响的随机试验。方法:通过1级高血压将血压高于最佳血压的参与者随机分为:1)实施既定建议的行为生活方式(BLS)干预; 2)实施既定建议加DASH饮食的BLS干预;或3)仅建议标准护理小组。 BLS的两种干预措施包括为期18个月的小组辅导和个人辅导。主要结局是6个月时的收缩压。其他结果包括6个月时舒张压BP和高半胱氨酸; 18个月时的收缩压和舒张压;在6和18个月时禁食脂质,葡萄糖和胰岛素;和子组中的效果。结论:PREMIER试验的结果将为实施多成分行为生活方式干预计划以控制血压和预防CVD提供科学依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号